Cargando…

Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy

BACKGROUND: Calcium ions (Ca(2+)) participates in various intracellular signal cascades and especially plays a key role in pathways relevant to cancer cells. Mitochondrial metabolism stimulated by calcium overload can trigger the opening of the mitochondrial permeability transition pore (MPTP), whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ying, Jing, Shisong, Liu, Sainan, Shen, Xizhong, Cai, Lihan, Zhu, Changfeng, Zhao, Yicheng, Pang, Maolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004178/
https://www.ncbi.nlm.nih.gov/pubmed/35413984
http://dx.doi.org/10.1186/s12951-022-01392-y
_version_ 1784686234515275776
author Zhou, Ying
Jing, Shisong
Liu, Sainan
Shen, Xizhong
Cai, Lihan
Zhu, Changfeng
Zhao, Yicheng
Pang, Maolin
author_facet Zhou, Ying
Jing, Shisong
Liu, Sainan
Shen, Xizhong
Cai, Lihan
Zhu, Changfeng
Zhao, Yicheng
Pang, Maolin
author_sort Zhou, Ying
collection PubMed
description BACKGROUND: Calcium ions (Ca(2+)) participates in various intracellular signal cascades and especially plays a key role in pathways relevant to cancer cells. Mitochondrial metabolism stimulated by calcium overload can trigger the opening of the mitochondrial permeability transition pore (MPTP), which leads to cancer cell death. METHODS: Herein, a mitochondrial pathway for tumour growth inhibition was built via the double-activation of MPTP channel. Fe(2+) doped covalent organic frameworks (COF) was synthesised and applied as template to grow CaCO(3) shell. Then O(2) was storaged into Fe(2+) doped COF, forming O(2)-FeCOF@CaCO(3) nanocomposite. After modification with folic acid (FA), O(2)-FeCOF@CaCO(3)@FA (OFCCF) can target breast cancer cells and realize PDT/Ca(2+) overload synergistic treatment. RESULTS: COF can induce the production of (1)O(2) under 650 nm irradiation for photodynamic therapy (PDT). Low pH and hypoxia in tumour microenvironment (TME) can activate the nanocomposite to release oxygen and Ca(2+). The released O(2) can alleviate hypoxia in TME, thus enhancing the efficiency of COF-mediated PDT. Abundant Ca(2+) were released and accumulated in cancer cells, resulting in Ca(2+) overload. Notably, the reactive oxygen species (ROS) and Ca(2+) overload ensure the sustained opening of MPTP, which leads to the change of mitochondria transmembrane potential, the release of cytochrome c (Cyt c) and the activation of caspases 3 for cancer cell apoptosis. CONCLUSION: This multifunctional nanosystem with TME responded abilities provided a novel strategy for innovative clinical cancer therapy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01392-y.
format Online
Article
Text
id pubmed-9004178
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90041782022-04-13 Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy Zhou, Ying Jing, Shisong Liu, Sainan Shen, Xizhong Cai, Lihan Zhu, Changfeng Zhao, Yicheng Pang, Maolin J Nanobiotechnology Research BACKGROUND: Calcium ions (Ca(2+)) participates in various intracellular signal cascades and especially plays a key role in pathways relevant to cancer cells. Mitochondrial metabolism stimulated by calcium overload can trigger the opening of the mitochondrial permeability transition pore (MPTP), which leads to cancer cell death. METHODS: Herein, a mitochondrial pathway for tumour growth inhibition was built via the double-activation of MPTP channel. Fe(2+) doped covalent organic frameworks (COF) was synthesised and applied as template to grow CaCO(3) shell. Then O(2) was storaged into Fe(2+) doped COF, forming O(2)-FeCOF@CaCO(3) nanocomposite. After modification with folic acid (FA), O(2)-FeCOF@CaCO(3)@FA (OFCCF) can target breast cancer cells and realize PDT/Ca(2+) overload synergistic treatment. RESULTS: COF can induce the production of (1)O(2) under 650 nm irradiation for photodynamic therapy (PDT). Low pH and hypoxia in tumour microenvironment (TME) can activate the nanocomposite to release oxygen and Ca(2+). The released O(2) can alleviate hypoxia in TME, thus enhancing the efficiency of COF-mediated PDT. Abundant Ca(2+) were released and accumulated in cancer cells, resulting in Ca(2+) overload. Notably, the reactive oxygen species (ROS) and Ca(2+) overload ensure the sustained opening of MPTP, which leads to the change of mitochondria transmembrane potential, the release of cytochrome c (Cyt c) and the activation of caspases 3 for cancer cell apoptosis. CONCLUSION: This multifunctional nanosystem with TME responded abilities provided a novel strategy for innovative clinical cancer therapy. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01392-y. BioMed Central 2022-04-12 /pmc/articles/PMC9004178/ /pubmed/35413984 http://dx.doi.org/10.1186/s12951-022-01392-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhou, Ying
Jing, Shisong
Liu, Sainan
Shen, Xizhong
Cai, Lihan
Zhu, Changfeng
Zhao, Yicheng
Pang, Maolin
Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy
title Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy
title_full Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy
title_fullStr Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy
title_full_unstemmed Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy
title_short Double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy
title_sort double-activation of mitochondrial permeability transition pore opening via calcium overload and reactive oxygen species for cancer therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004178/
https://www.ncbi.nlm.nih.gov/pubmed/35413984
http://dx.doi.org/10.1186/s12951-022-01392-y
work_keys_str_mv AT zhouying doubleactivationofmitochondrialpermeabilitytransitionporeopeningviacalciumoverloadandreactiveoxygenspeciesforcancertherapy
AT jingshisong doubleactivationofmitochondrialpermeabilitytransitionporeopeningviacalciumoverloadandreactiveoxygenspeciesforcancertherapy
AT liusainan doubleactivationofmitochondrialpermeabilitytransitionporeopeningviacalciumoverloadandreactiveoxygenspeciesforcancertherapy
AT shenxizhong doubleactivationofmitochondrialpermeabilitytransitionporeopeningviacalciumoverloadandreactiveoxygenspeciesforcancertherapy
AT cailihan doubleactivationofmitochondrialpermeabilitytransitionporeopeningviacalciumoverloadandreactiveoxygenspeciesforcancertherapy
AT zhuchangfeng doubleactivationofmitochondrialpermeabilitytransitionporeopeningviacalciumoverloadandreactiveoxygenspeciesforcancertherapy
AT zhaoyicheng doubleactivationofmitochondrialpermeabilitytransitionporeopeningviacalciumoverloadandreactiveoxygenspeciesforcancertherapy
AT pangmaolin doubleactivationofmitochondrialpermeabilitytransitionporeopeningviacalciumoverloadandreactiveoxygenspeciesforcancertherapy